73 F.4th 1220
11th Cir.2023Background
- MiMedx Group, its former executives (Petit, Senken, Taylor), and auditor Cherry Bekaert were sued in a consolidated securities-fraud class action alleging long-running revenue-inflation schemes (channel-stuffing, undisclosed distributor side arrangements, manipulation of reimbursement and donations) that misstated financials from 2012–2018.
- Lead plaintiff Carpenters purchased MiMedx shares in Aug–Oct 2017, sold those shares in Dec 2017, re-purchased in Jan 2018, and sold again on Feb 26, 2018; the class period ran Mar 7, 2013–June 29, 2018.
- Carpenters alleged the truth leaked out through a series of partial disclosures (press releases, analyst/short-seller reports, news articles, whistleblower suits, audit-committee and government investigations) culminating in a June–July 2018 restatement and executive resignations.
- The district court dismissed the second amended complaint, holding (1) Carpenters lacked Article III standing because it sold all shares before any corrective disclosure removed fraud-induced inflation, and (2) the complaint failed to plead loss causation because the earlier alleged disclosures were not corrective.
- On appeal the Eleventh Circuit vacated the standing ruling (distinguishing Article III traceability from the merits) but affirmed dismissal for failure to plead loss causation and affirmed denial of post-judgment relief/leave to amend.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Article III standing (traceability) for §10(b) claims | Carpenters alleged it lost money due to defendants’ misrepresentations and thus had traceable injury and redressability. | Defendants argued Carpenters sold before any corrective disclosure, so losses weren’t traceable to alleged fraud. | Court: District court erred—standing was met at filing (traceability and redressability); vacated standing dismissal. |
| Loss causation — whether alleged disclosures were corrective | Carpenters: truth leaked via a series of partial disclosures (press releases, analyst/short-seller reports, lawsuits, investigations) that caused stock drops and removed inflation. | Defendants: the cited items were misleading statements, repackagings of public info, or mere investigation announcements—none revealed new truth showing prior falsity. | Court: Affirmed dismissal—alleged disclosures were not corrective as pleaded; Carpenters sold before truth was revealed, so no loss causation. |
| Analyst/news reports as corrective disclosures | Carpenters: analyst and investigative reports uncovered new, nonpublic facts and cumulatively revealed fraud. | Defendants: reports repackaged public information; repackaging is insufficient to reveal fraud. | Court: Held reports did not disclose new information and therefore were not corrective (followed Meyer). |
| Post-judgment relief and leave to amend | Carpenters sought reconsideration under Rules 59/60 and leave to add Amalgamated Bank as an end-of-period plaintiff to cure standing/loss-causation defects. | Defendants opposed; district court said Rule 15 inapplicable post-judgment and denied relief. | Court: Affirmed denial—no abuse of discretion in rejecting relitigation and denying extraordinary relief/leave to amend post-judgment. |
Key Cases Cited
- FindWhat Inv. Grp. v. FindWhat.com, 658 F.3d 1282 (11th Cir. 2011) (explains fraud-on-the-market theory and corrective-disclosure framework)
- Meyer v. Greene, 710 F.3d 1189 (11th Cir. 2013) (announcing that an investigation announcement alone generally is not a corrective disclosure; guidance on partial disclosures)
- Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005) (holding that an inflated purchase price alone does not establish loss causation; a corrective disclosure is required)
- Basic Inc. v. Levinson, 485 U.S. 224 (1988) (adopting the efficient-market presumption for reliance in fraud-on-the-market cases)
- Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27 (2011) (reciting elements of a §10(b) claim)
- TransUnion LLC v. Ramirez, 141 S. Ct. 2190 (2021) (articulating Article III standing requirements and traceability)